Free Trial

SONOVA (OTCMKTS:SONVY) Stock Rating Upgraded by Zacks Research

SONOVA logo with Medical background

Key Points

  • SONOVA's stock rating was upgraded by Zacks Research from "hold" to "strong-buy," indicating increased confidence among analysts.
  • Other analysts have provided mixed ratings, with two giving a "Strong Buy," while others have assigned "Hold" and "Sell" ratings, leading to an average rating of "Hold" overall.
  • The current stock price for SONOVA is approximately $54.99, with a 12-month high of $77.56 and a low of $52.83, showcasing some fluctuation in performance over the year.
  • MarketBeat previews the top five stocks to own by November 1st.

SONOVA (OTCMKTS:SONVY - Get Free Report) was upgraded by research analysts at Zacks Research from a "hold" rating to a "strong-buy" rating in a research note issued to investors on Thursday,Zacks.com reports.

Other research analysts have also recently issued reports about the company. Rothschild Redb upgraded SONOVA from a "strong sell" rating to a "hold" rating in a report on Monday, October 6th. Barclays cut SONOVA from a "hold" rating to a "strong sell" rating in a report on Friday, June 20th. Finally, Sanford C. Bernstein upgraded SONOVA from a "hold" rating to a "strong-buy" rating in a report on Friday, July 18th. Two research analysts have rated the stock with a Strong Buy rating, four have assigned a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of "Hold".

Read Our Latest Stock Report on SONVY

SONOVA Price Performance

SONVY stock opened at $54.99 on Thursday. The company has a current ratio of 1.27, a quick ratio of 0.96 and a debt-to-equity ratio of 0.45. SONOVA has a 12-month low of $52.83 and a 12-month high of $77.56. The business's 50-day moving average is $57.05 and its 200 day moving average is $58.81.

SONOVA Company Profile

(Get Free Report)

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.

Further Reading

Analyst Recommendations for SONOVA (OTCMKTS:SONVY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in SONOVA Right Now?

Before you consider SONOVA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SONOVA wasn't on the list.

While SONOVA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.